|1.||Jeon, Ji-Young: 1 article (01/2011)|
|2.||Son, Hyeong-U: 1 article (01/2011)|
|3.||Lee, Sang-Han: 1 article (01/2011)|
|4.||Nam, Sung-Hee: 1 article (01/2011)|
|5.||Yoon, Cheol-Sik: 1 article (01/2011)|
|6.||Lee, Hei-Sam: 1 article (01/2011)|
|7.||Lee, Myeong-Lyeol: 1 article (01/2011)|
|8.||Bowers, Lisa C: 1 article (06/2006)|
|9.||Phillips, Jennifer N: 1 article (06/2006)|
|10.||Didier, E S: 1 article (06/2006)|
06/01/2006 - "The purpose of this study was to apply an in vitro drug screening assay for Encephalitozoon intestinalis and Vittaforma corneae and an in vivo athymic mouse model of V. corneae infection to assess the efficacy of TNP-470 (a semisynthetic analogue of fumagillin), ovalicin, and eight ovalicin derivatives. "
06/01/2006 - "None of the treated athymic mice survived the V. corneae infection, but they did survive statistically significantly longer than the untreated controls after daily treatment with fumagillin administered at 5, 10, and 20 mg/kg of body weight subcutaneously (s.c.), TNP-470 administered at 20 mg/kg intraperitoneally (i.p.), or ovalicin administered at 5 mg/kg s.c. "
|2.||Atopic Dermatitis (Atopic Eczema)
01/01/2011 - "Ovalicin ameliorates compound 48/80-induced atopic dermatitis-related symptoms."
01/01/2011 - "To assess whether ovalicin has potential in ameliorating atopic dermatitis-related symptoms in mice, we first sensitized skin in the dorsal neck of Balb/c mice using compound 48/80, and scrutinized whether the compound affected the atopic dermatitis-related symptoms. "
07/01/1996 - "Chlovalicin, a ovalicin derivative with a chlorinated methylene moiety at the C-1 position of the cyclohexane ring, dose-dependently inhibited the growth of IL-6 dependent MH60 cells (IC50, 7.5 microM) in the presence of 0.2 U/ml IL-6 and, to a lesser extent, the growth of B16 melanoma cells (IC50, 38 microM). "
|2.||O-(chloroacetylcarbamoyl)fumagillol (TNP 470)
|4.||Interleukin-6 (Interleukin 6)
|6.||DNA (Deoxyribonucleic Acid)